CSIMarket


Acelrx Pharmaceuticals Inc  (ACRX)
Other Ticker:  
 

Acelrx Pharmaceuticals Inc

ACRX's Fundamental analysis








Acelrx Pharmaceuticals Inc's sales fell in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 2159

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.24 %

Acelrx Pharmaceuticals Inc net loss deacreased by in I. Quarter 2023 year on year, Acelrx Pharmaceuticals Inc net loss increased by -6.02 % in I. Quarter 2023 year on year,

More on ACRX's Growth


Acelrx Pharmaceuticals Inc
realized net loss in trailing twelve months.

Acelrx Pharmaceuticals Inc realized cash outflow of $ -0.78per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 9.1.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.05.


More on ACRX's Valuation
 
 Total Debt (Millions $) 3
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.50

Acelrx Pharmaceuticals Inc
realized net loss in trailing twelve months.

Acelrx Pharmaceuticals Inc realized cash outflow of $ -0.78per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 9.1.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.05.

Acelrx Pharmaceuticals Inc Price to Book Ratio is at 0.85 higher than Indusry Avg. of -1004.47, and lower than S&P 500 Avg. of 1255.17

More on ACRX's Valuation

  Market Capitalization (Millions $) 12
  Shares Outstanding (Millions) 11
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) 43
  Cash Flow (TTM) (Millions $) -8
  Capital Exp. (TTM) (Millions $) 0
  Total Debt (Millions $) 3
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 0.50

  Market Capitalization (Millions $) 12
  Shares Outstanding (Millions) 11
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) 43
  Cash Flow (TTM) (Millions $) -8
  Capital Exp. (TTM) (Millions $) 0





  Ratio
   Capital Ratio (MRQ) 1.84
  Total Debt to Equity (MRQ) 0.23
  Tangible Leverage Ratio (MRQ) 2.21
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071